Management of human immunodeficiency virus infection in advanced age

JAMA

Volumn 309, Issue 13, 2013, Pages 1397-1405

  Greene, Meredith ^a   Justice, Amy C ^c   Lampiris, Harry W ^a,d   Valcour, Victor ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUDESONIDE; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CLOPIDOGREL; CORTICOSTEROID DERIVATIVE; DIDANOSINE; EFAVIRENZ; FLUTICASONE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; NUCLEOSIDE DERIVATIVE; OPIATE DERIVATIVE; PHOSPHODIESTERASE V INHIBITOR; PROTEINASE INHIBITOR; PROTON PUMP INHIBITOR; RALTEGRAVIR; RITONAVIR; STAVUDINE; TENOFOVIR; THYMIDINE DERIVATIVE; UNINDEXED DRUG; WARFARIN;

ADRENAL INSUFFICIENCY; AGING; ARTICLE; BONE DENSITY; CD4 LYMPHOCYTE COUNT; CHRONIC KIDNEY DISEASE; COMORBIDITY; CUSHING SYNDROME; DISEASE COURSE; DRUG ANTAGONISM; DRUG MEGADOSE; DRUG POTENTIATION; FATTY LIVER; FUNCTIONAL STATUS; GERIATRIC PATIENT; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; INAPPROPRIATE PRESCRIBING; INFECTION PREVENTION; LIFE EXPECTANCY; LIVER TOXICITY; LONELINESS; MASS SCREENING; PATIENT CARE; PATIENT COMPLIANCE; POLYPHARMACY; PRIORITY JOURNAL; SIDE EFFECT; SOCIAL ISOLATION; SOCIAL SUPPORT; TERMINAL CARE;

EID: 84875655420     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.2963     Document Type: Article

References (78)

1. Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293-299.
2. Prejean J, Song R, Hernandez A, et al HIV Incidence Surveillance Group. Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011;6(8):e17502.
3. Linley L, Prejean J, An Q, Chen M, Hall HI. Racial/ethnic disparities in HIV diagnoses among persons aged 50 years and older in 37 US States, 2005-2008. Am J Public Health. 2012;102(8):1527-1534.
4. Jacobs RJ, Kane MN. Theory-based policy development for HIV prevention in racial/ethnic minority midlife and older women. J Women Aging. 2009;21(1):19-32.
5. Smith RD, Delpech VC, Brown AE, Rice BD. HIV transmission and high rates of late diagnoses among adults aged 50 years and over. AIDS. 2010;24(13):2109-2115.
6. Milaszewski D, Greto E, Klochkov T, Fuller-Thomson E. A systematic review of education for the prevention of HIV/AIDS among older adults. J Evid Based Soc Work. 2012;9(3):213-230.
7. Sankar A, Nevedal A, Neufeld S, Berry R, Luborsky M. What do we know about older adults and HIV? a review of social and behavioral literature. AIDS Care. 2011;23(10):1187-1207.
8. Lindau ST, Schumm LP, Laumann EO, Levinson W,O'Muircheartaigh CA, Waite LJ. A study of sexuality and health among older adults in the United States. N Engl J Med. 2007;357(8):762-774. (Pubitemid 47295643)
9. Adekeye OA, Heiman HJ, Onyeabor OS, Hyacinth HI. The new invincibles: HIV screening among older adults in the US. PLoS One. 2012;7(8):e43618.
10. Zablotsky D, Kennedy M. Risk factors and HIV transmission to midlife and older women: knowledge, options, and the initiation of safer sexual practices. J Acquir Immune Defic Syndr. 2003;33(suppl 2):S122-S130. (Pubitemid 36801610)
11. Henderson SJ, Bernstein LB, George DM, Doyle JP, Paranjape AS, Corbie-Smith G. Older women and HIV: how much do they know and where are they getting their information? J Am Geriatr Soc. 2004;52(9):1549-1553. (Pubitemid 39209606)
12. Schensul JJ, Levy JA, Disch WB. Individual, contextual, and social network factors affecting exposure to HIV/AIDS risk among older residents living in low-income senior housing complexes. J Acquir Immune Defic Syndr. 2003;33(suppl 2):S138-S152. (Pubitemid 36801612)
13. Kwiatkowski CF, Booth RE. HIV risk behaviors among older American drug users. J Acquir Immune Defic Syndr. 2003;33(suppl 2):S131-S137. (Pubitemid 36801611)
14. Chou R. Routine screening for chronic human immunodeficiency virus infection: why don't the guidelines agree? Epidemiol Rev. 2011;33(1):7-19.
15. US Preventive Services Task Force. Screening for HIV: recommendation statement. Ann Intern Med. 2005;143(1):32-37.
16. Branson BM, Handsfield HH, Lampe MA, et al Centers for Disease Control and Prevention (CDC). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14):1-17, quiz CE1-CE4.
17. Abrass CK, Appelbaum JS, Boyd CM, et al Work Group for HIV and Aging Consensus Project. Summary report from the Human Immunodeficiency Virus and Aging Consensus Project: treatment strategies for clinicians managing older individuals with the human immunodeficiency virus. J Am Geriatr Soc. 2012;60(5):974-979.
18. Sanders GD, Bayoumi AM, HolodniyM, Owens DK. Cost-effectiveness of HIV screening in patients older than 55 years of age. Ann Intern Med. 2008;148(12):889-903. (Pubitemid 351860821)
19. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach 2010 revision. http://www.who.int/hiv/pub/arv/adult2010/en/index.html. Accessed February 13, 2013.
20. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed February 13, 2013.
21. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA. 2012;308(4):387-402.
22. Silverberg MJ, Leyden W, Horberg MA, DeLorenze GN, Klein D, Quesenberry CP Jr. Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med. 2007;167(7):684-691. (Pubitemid 46598461)
23. Althoff KN, Justice AC, Gange SJ, et al North American AIDS Cohorts Collaboration on Research, Design (NA-ACCORD). Virologic and immunologic response to HAART, by age and regimen class. AIDS. 2010;24(16):2469-2479.
24. Tumbarello M, Rabagliati R, de Gaetano Donati K, et al. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy. BMC Infect Dis. 2004;4:46.
25. Yehia BR, Fleishman JA, Metlay JP, Moore RD, Gebo KA. Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA. 2012;308(4):339-342.
26. Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(suppl 1):S19-S25. (Pubitemid 38365902)
27. Rhee MS, Greenblatt DJ. Pharmacologic consideration for the use of antiretroviral agents in the elderly. J Clin Pharmacol. 2008;48(10):1212-1225.
28. Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793-800.
29. Aberg JA, Kaplan JE, Libman H, et al HIV Medicine Association of the Infectious Diseases Society of America. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(5):651-681.
30. + count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS. 2008;22(7):841-848.
31. Monforte Ad, Abrams D, Pradier C, et al; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS. 2008;22(16):2143-2153.
32. + count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283-2296.
33. High KP, Brennan-Ing M, Clifford DB, et al OAR Working Group on HIV and Aging. HIV and aging: state of knowledge and areas of critical need for research: a report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012;60(suppl 1):S1-S18.
34. Bedimo RJ, McGinnis KA, Dunlap M, Rodriguez-Barradas MC, Justice AC. Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr. 2009;52(2):203-208.
35. SilverbergMJ, Lau B, Justice AC, et al; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis. 2012;54(7):1026-1034.
36. Rosenthal E, Pialoux G, Bernard N, et al GERMIVIC Joint Study Group. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). J Viral Hepat. 2007;14(3):183-188.
37. Palefsky JM, Holly EA, Efirdc JT, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS. 2005;19(13):1407-1414. (Pubitemid 41800677)
38. Neuhaus J, Angus B, Kowalska JD, et al; INSIGHT SMART and ESPRIT study groups. Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. AIDS. 2010;24(5):697-706.
39. Petoumenos K, Worm S, Reiss P, et al; D:A:D Study Group. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*). HIV Med. 2011;12(7):412-421.
40. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506-2512. (Pubitemid 47037350)
41. Freiberg MS, Chang CC, Kuller LH, et al. HIV infection and the risk of acute myocardial infarction [published online ahead of press]. JAMA Intern Med. 2013:1-9. doi:10.1001/jamainternmed.2013.3728.
42. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006;20(17):2165- 2174. (Pubitemid 44684707)
43. Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009; 52(5):611-622.
44. Balderson BH, Grothaus L, Harrison RG, McCoy K, Mahoney C, Catz S. Chronic illness burden and quality of life in an aging HIV population. AIDS Care. 2013;25(4):451-458.
45. Morgan EE, Iudicello JE, Weber E, et al HIV Neurobehavioral Research Program (HNRP) Group. Synergistic effects of HIV infection and older age on daily functioning. J Acquir Immune Defic Syndr. 2012;61(3):341-348.
46. Oursler KK, Goulet JL, Crystal S, et al. Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the Veterans Aging Cohort Study. AIDS Patient Care STDS. 2011;25(1):13-20.
47. Desquilbet L, Jacobson LP, Fried LP, et al. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci. 2011;66(9):1030-1038.
48. Desquilbet L, Jacobson LP, Fried LP, et al Multicenter AIDS Cohort Study. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci. 2007;62(11):1279-1286. (Pubitemid 350287617)
49. Hasse B, Ledergerber B, Furrer H, et al Swiss HIV Cohort Study. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis. 2011;53(11):1130-1139.
50. Marzolini C, Elzi L, Gibbons S, et al Swiss HIV Cohort Study. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antivir Ther. 2010;15(3):413-423.
51. Furler MD, Einarson TR, Walmsley S, Millson M, Bendayan R. Polypharmacy in HIV: impact of data source and gender on reported drug utilization. AIDS Patient Care STDS. 2004;18(10):568-586. (Pubitemid 39431032)
52. Krentz HB, Cosman I, Lee K, Ming JM, Gill MJ. Pill burden in HIV infection: 20 years of experience. Antivir Ther. 2012;17(5):833-840.
53. Steinman MA, Hanlon JT. Managing medications in clinically complex elders: "There's got to be a happy medium." JAMA. 2010;304(14):1592- 1601.
54. University of Liverpool. Drug interaction charts. www.hiv- druginteractions.org. Accessed February 1, 2013.
55. Emlet CA. An examination of the social networks and social isolation in older and younger adults living with HIV/AIDS. Health Soc Work. 2006;31(4):299-308.
56. Crystal S, Akincigil A, Sambamoorthi U, et al. The diverse older HIV-positive population: a national profile of economic circumstances, social support, and quality of life. J Acquir Immune Defic Syndr. 2003;33(suppl 2):S76-S83. (Pubitemid 36801605)
57. Owen G, Catalan J. 'We never expected this to happen': narratives of ageing with HIV among gay men living in London, UK. Cult Health Sex. 2012;14(1):59-72.
58. Johnson CJ, Heckman TG, Hansen NB, Kochman A, Sikkema KJ. Adherence to antiretroviral medication in older adults living with HIV/AIDS: a comparison of alternative models. AIDS Care. 2009;21(5):541-551.
59. Bianco JA, Heckman TG, Sutton M, Watakakosol R, Lovejoy T. Predicting adherence to antiretroviral therapy in HIV-infected older adults: the moderating role of gender. AIDS Behav. 2011;15(7):1437-1446.
60. Heckman TG, Sikkema KJ, Hansen N, Kochman A, Heh V, Neufeld S; AIDS and Aging Research Group. A randomized clinical trial of a coping improvement group intervention for HIV-infected older adults. J Behav Med. 2011;34(2):102-111.
61. Emlet CA, Tozay S, Raveis VH. "I'm not going to die from the AIDS": resilience in aging with HIV disease. Gerontologist. 2011;51(1):101-111.
62. US Preventive Services Task Force. Recommendations. http://www. uspreventiveservicestaskforce.org/recommendations.htm. Accessed February 13, 2013.
63. Lee S, Smith A, Widera E. Estimating prognosis for elders. ePrognosis website. http://www.eprognosis.org.Accessed February 7, 2013.
64. Justice AC, McGinnis KA, Skanderson M, et al VACS Project Team. Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med. 2010;11(2):143-151.
65. Tate JP, Justice AC, Hughes MD, et al. An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS. 2013;27(4):563-572.
66. Akgün KM, Gordon K, Pisani M, et al. Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr. 2013;62(1):52-59.
67. Womack JA, Goulet JL, Gibert C, et al. Physiologic frailty and fragility fracture in HIV-infected male veterans [published online ahead of print March 13, 2013]. Clin Infect Dis. 2013.
68. Braithwaite RS, Fiellin D, Justice AC. The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines. Med Care. 2009;47(6):610-617.
69. Walter LC, Covinsky KE. Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001;285(21):2750-2756. (Pubitemid 32525372)
70. Wenger NS, Kanouse DE, Collins RL, et al. End-of-life discussions and preferences among persons with HIV. JAMA. 2001;285(22):2880-2887. (Pubitemid 32537352)
71. Erlandson KM, Allshouse AA, Duong S, MaWhinney S, Kohrt WM, Campbell TB. HIV, aging, and advance care planning: are we successfully planning for the future? J Palliat Med. 2012;15(10):1124-1129.
72. Selwyn PA, Rivard M. Palliative care for AIDS: challenges and opportunities in the era of highly active anti-retroviral therapy. J Palliat Med. 2003;6(3):475-487.
73. Simms V, Higginson IJ, Harding R. Integration of palliative care throughout HIV disease. Lancet Infect Dis. 2012;12(7):571-575.
74. O'Brien K, Nixon S, Tynan AM, Glazier R. Aerobic exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev. 2010;4(8):CD001796.
75. Handford CD, Tynan AM, Rackal JM, Glazier RH. Setting and organization of care for persons living with HIV/AIDS. Cochrane Database Syst Rev. 2006;19(3):CD004348.
76. Waters L, Patterson B, Scourfield A, et al. A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experience. Int J STD AIDS. 2012;23(8):546-552.
77. Chu C, Selwyn PA. An epidemic in evolution: the need for new models of HIV care in the chronic disease era. J Urban Health. 2011;88(3):556-566.
78. Rabkin M, Kruk ME, El-Sadr WM. HIV, aging and continuity care: strengthening health systems to support services for noncommunicable diseases in low-income countries. AIDS. 2012;26(suppl 1):S77-S83.